Gaspar M M, Martins M B, Corvo M L, Cruz M E M
Departamento de Biotecnologia, Unidade Novas Formas de Agentes Bioactivos, Instituto Nacional de Engenharia e Tecnologia Industrial, Estrada do Paço do Lumiar 22, 1649-038 Lisbon, Portugal.
Biochim Biophys Acta. 2003 Jan 31;1609(2):211-7. doi: 10.1016/s0005-2736(02)00702-2.
Superoxide dismutase (SOD) was chemically modified by covalent linkage of fatty acid chains to the accessible epsilon-amino groups of the enzyme. This acylation method gave rise to a different enzyme entity (Ac-SOD) as evidenced by different physicochemical properties such as octanol/water partition coefficient and isoelectric point (pI) as compared to SOD. Ac-SOD was incorporated in conventional and long-circulating liposomes (LCL) and characterized in terms of incorporation efficiency, protein to lipid ratio (Prot/Lip), enzymatic activity retention and zeta potential. The observation that Ac-SOD liposomes present enzymatic activity on their external surface indicates that these formulations can act independent of rate and extent of enzyme release as required in case of SOD liposomes. The decrease of superficial charge of liposomal formulations containing Ac-SOD, as compared to SOD liposomes, may be related to the negatively charged enzyme molecules localized on the liposome surface. The comparative characterization of Ac-SOD and SOD liposomal formulations evidenced that the two enzyme forms differ substantially regarding their intraliposomal location: SOD tends to be localized in the internal aqueous spaces, whereas Ac-SOD is expected to be localized in the lipid bilayers of the liposomes, partially buried into the outer surface and exposed to the external medium. These liposomal structures with surface-exposed SOD were designated as Ac-SOD enzymosomes. The properties of these enzymosomes may influence the therapeutic effect, as the release of the enzyme from extravasated vesicles is no longer a necessary requirement for achieving dismutating activity within the inflamed target site.
超氧化物歧化酶(SOD)通过脂肪酸链与酶可及的ε-氨基共价连接进行化学修饰。与SOD相比,这种酰化方法产生了一种不同的酶实体(Ac-SOD),这可通过不同的物理化学性质如辛醇/水分配系数和等电点(pI)来证明。Ac-SOD被包封在常规脂质体和长循环脂质体(LCL)中,并根据包封效率、蛋白质与脂质比(Prot/Lip)、酶活性保留和ζ电位进行表征。Ac-SOD脂质体在其外表面呈现酶活性这一观察结果表明,这些制剂可以独立于酶释放的速率和程度发挥作用,这与SOD脂质体的情况不同。与SOD脂质体相比,含有Ac-SOD的脂质体制剂表面电荷的降低可能与位于脂质体表面的带负电荷的酶分子有关。Ac-SOD和SOD脂质体制剂的比较表征证明,这两种酶形式在脂质体内的位置有很大差异:SOD倾向于定位在内部水相中,而Ac-SOD预计定位在脂质体的脂质双层中,部分埋入外表面并暴露于外部介质。这些具有表面暴露SOD的脂质体结构被称为Ac-SOD酶体。这些酶体的性质可能会影响治疗效果,因为从外渗囊泡中释放酶不再是在炎症靶部位实现歧化活性的必要条件。